Selank Peptide

Selank is a synthetic peptide that has been widely explored in preclinical research for its role in modulating neurochemical signaling and stress-related responses. Originally developed as an analog of the naturally occurring immunomodulatory peptide tuftsin, Selank consists of seven amino acids and has been studied for its stability and activity within experimental systems. Unlike mitochondrial-derived peptides, Selank is engineered and examined primarily for its influence on central nervous system signaling pathways.

Across in vitro experiments and animal models, Selank has been investigated for its interactions with neurotransmitter systems, particularly those associated with gamma-aminobutyric acid (GABA), serotonin, and dopamine regulation. Research suggests that Selank may influence receptor binding dynamics, enzymatic activity, and gene expression related to neuroplasticity and stress adaptation. These effects have been evaluated in experimental models involving cognitive stress, behavioral conditioning, inflammatory responses, and neurochemical imbalance.

In addition to its neurological research profile, Selank has also been examined for potential immunomodulatory activity in preclinical settings. Findings indicate that the peptide may interact with cytokine expression and immune signaling pathways under controlled experimental conditions. Studies often utilize models exposed to environmental, physiological, or induced stressors to observe these responses.

Modified and stabilized forms of Selank have been explored to improve experimental consistency and duration of action in laboratory settings. All observations described are derived exclusively from non-clinical research. No human trials have established safety, pharmacokinetics, dosing parameters, or therapeutic applications, and all findings remain investigational.